MGRX
Income statement / Annual
Last year (2025), Mangoceuticals Inc's total revenue was $456.02 K,
a decrease of 25.96% from the previous year.
In 2025, Mangoceuticals Inc's net income was -$20.64 M.
See Mangoceuticals Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$456.02 K |
$615.87 K |
$731.49 K |
$8.94 K |
$0.00 |
| Cost of Revenue |
$205.64 K
|
$235.91 K
|
$299.99 K
|
$4.09 K
|
$0.00
|
| Gross Profit |
$250.39 K
|
$379.96 K
|
$431.50 K
|
$4.85 K
|
$0.00
|
| Gross Profit Ratio |
0.55
|
0.62
|
0.59
|
0.54
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$15.90 M
|
$6.42 M
|
$3.32 M
|
$1.64 M
|
$0.00
|
| Selling & Marketing Expenses |
$822.86 K
|
$1.48 M
|
$2.10 M
|
$352.86 K
|
$0.00
|
| Selling, General & Administrative Expenses |
$16.72 M
|
$7.90 M
|
$5.42 M
|
$2.00 M
|
$17.52 K
|
| Other Expenses |
$2.68 M
|
$453.79 K
|
$4.23 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$19.41 M
|
$8.35 M
|
$9.65 M
|
$2.00 M
|
$17.52 K
|
| Cost And Expenses |
$19.61 M
|
$8.59 M
|
$9.95 M
|
$2.00 M
|
$17.52 K
|
| Interest Income |
$0.00
|
$0.00
|
$6.47 K
|
$0.00
|
$0.00
|
| Interest Expense |
$103.51 K
|
$13.70 K
|
$0.00
|
$6.47 K
|
$181.00
|
| Depreciation & Amortization |
$1.72 M
|
$721.53 K
|
$24.89 K
|
$3.86 K
|
$0.00
|
| EBITDA |
-$18.82 M |
-$7.96 M |
-$8.09 M |
-$1.99 M |
-$17.52 K |
| EBITDA Ratio |
-41.26
|
-12.93
|
-11.06
|
-222.36
|
0
|
| Operating Income Ratio |
-42
|
-12.94
|
-12.6
|
-222.8
|
0
|
| Total Other Income/Expenses Net |
-$1.49 M
|
-$735.00 K
|
$6.47 K
|
-$6.47 K
|
-$181.00
|
| Income Before Tax |
-$20.64 M
|
-$8.71 M
|
-$9.21 M
|
-$2.00 M
|
-$17.70 K
|
| Income Before Tax Ratio |
-45.27
|
-14.14
|
-12.59
|
-223.52
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$20.64 M
|
-$8.71 M
|
-$9.21 M
|
-$2.00 M
|
-$17.70 K
|
| Net Income Ratio |
-45.27
|
-14.14
|
-12.59
|
-223.52
|
0
|
| EPS |
-2.05 |
-4.3993 |
-8.58 |
-1.7309 |
-0.0177 |
| EPS Diluted |
-2.05 |
-4.3993 |
-8.58 |
-1.7309 |
-0.0177 |
| Weighted Average Shares Out |
$10.07 M
|
$1.98 M
|
$1.07 M
|
$1.15 M
|
$997.67 K
|
| Weighted Average Shares Out Diluted |
$10.07 M
|
$1.98 M
|
$1.07 M
|
$1.15 M
|
$997.67 K
|
| Link |
|
|
|
|
|
